Obesity raises the risk of several health problems, including insulin resistance, type 2 diabetes, Alzheimer’s disease, cardiovascular disease, stroke, sleep apnea, slow wound healing, cancer, and others. Chronic adipose tissue inflammation has a significant role in obesity-related comorbidities. Obesity boosts pro-inflammatory helper T type 1 (Th1) cells, cytotoxic T cells, and M1-like macrophages while reducing regulatory T lymphocytes (Treg), resulting in chronic low-grade inflammation. Neutrophil granulocytes are associated with chronic inflammation and metabolic disorders. In a recent study at the Ohio State University, researchers investigated the role of visceral adipose tissue (VAT) neutrophils in systemic metabolism disruption and insulin resistance related to obesity.
The researchers explored the transcriptional profile of VAT neutrophils in human obesity and their potential link to gut bacterial translocation. To establish a causal relationship between gut microbiota changes and VAT neutrophilia, they administered human feces from lean and obese individuals into microbiome-depleted C57BL/6 mice. They collected epididymal VAT (eVAT), spleen, liver and lung samples for flow cytometry, gene expression analysis and 16S sequencing. A group of lean, metabolically healthy patients additionally consumed an additional 1,320 kcal, with more than 50% total fat and more than 10% saturated fat. The researchers quantified neutrophil abundance as a percentage of the CD45+ cells in the stromal vascular fraction (SVF) using flow cytometry.
To investigate the potential for bacterial translocations driving recruitment of neutrophils to visceral adipose tissues, the researchers developed human-microbiota avatar mice by depriving the murine microbiota using broad-spectrum antimicrobials and antifungals and recolonizing with stool from obese or non-obese human subjects or control saline. They fed mice high-fat diets (HFD) or regular chow over five days, after which they sampled several tissues, including VAT, for immunological analysis. The researchers investigated whether the VAT-isolated neutrophil expression might be detected elsewhere in the body. Obese individuals showed higher circulating leptin, insulin, and triglycerides, decreased adiponectin, and higher insulin resistance.
They were older, had higher neutrophil abundance, and reported increased plasma zonulin and lipopolysaccharide-binding protein (LBP). Obese individuals showed Streptococcaceae and Ruminococaceae more prevalent in their gut microbiomes. The team noted Marvinobryantia enrichment in lean VAT and Pseudomonas enrichment in VAT obtained from HFD mice gavaged with the fecal microbiome of obese individuals. Obese humans with increased neutrophilic recruitment in their visceral adipose tissues showed Proteobacteria enrichment. HFD caused bacterial translocation into the liver, leading to VAT neutrophil accumulation and pro-inflammatory T cell changes among obese humans and mice.
Only mice fed a high-fat diet and feces from obese individuals exhibited higher VAT neutrophil counts. A VAT-isolated neutrophil signature was related to overall survival in obesity-related cancers, associated with elevated insulin, leptin, triglycerides, decreased adiponectin and advanced age. Transcriptome analysis revealed that VAT neutrophils have more inflammation-related genes than peripheral blood neutrophils. VAT neutrophil proportion is correlated with adipocyte interleukin-1 beta (IL-1β), IL-8, inflammasome NLRP3 and leptin (LEP) gene expression. Females with obese VAT had more neutrophils than lean individuals. Human VAT neutrophils showed distinct gene expression related to inflammation, chemotaxis, extracellular matrix production and oxidative stress.
These upregulated genes indicate partial neutrophil activation, while increased genes related to bactericidal activity suggest bacterial contact. The VIN-type signature, distinct from peripheral blood neutrophils, was distinguished by pro-inflammatory mediators like IL-1β, IL-8, plasminogen activator, urokinase receptor (PLAUR), TREM1 receptor, nicotinamide phosphoribosyl transferase (NAMPT), prostaglandin-endoperoxide synthase 2 (PTGS2), protein phosphatase-1 regulatory subunit 15A (PPP1R15A) and superoxide dismutase (SOD). Therefore, persistent low-grade inflammation associated with obesity carries actually a molecular signature that is possible to take advantage of for treating inflammatory obesity consequences such as insulin resistance in diseases like Chron’s disease, metabolic syndrome and even colon cancer.
- Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.
Scientific references
Shantaram D et al. Nat Commun. 2024 Jun; 15(1):5434.
Bubnovskaya L et al. Exp Oncol. 2023 Jun; 45(1):88-98.
Uribe-Querol E, Rosales C. Cells 2022 Jun; 11(12):1883.